Breakthrough in Refractory Pregnancy Complications! Simvastatin + Placenta Chip Unlocks New Therapeutic Strategy for OAPS
Pregnancy is usually a journey full of anticipation, but for some women, obstetric antiphospholipid syndrome (OAPS) strikes like an unexpected storm—recurrent miscarriage, fetal growth restriction, severe preeclampsia, and other adverse outcomes leave 20%–30% of patients facing difficult